483Nov 4, 2022

483 Document: Boehringer Ingelheim Fremont, Inc.

Jeffrey P. Raimondi, FDA Investigator Christopher R. Czajka, FDA Investigator

FDANews 483 Boehringer Ingelheim Fremont, Inc. Nov 4 2022 top

Jeffrey P. Raimondi FDA Investigator Christopher R. Czajka FDA Investigator

On Nov 04, 2022, the FDA inspected Boehringer Ingelheim Fremont, Inc.'s Fremont site. Explore the inspectional observations.